655P Prognostic significance of docetaxel (D) plus androgen-deprivation therapy (ADT) in patients (p) with metastatic castration-sensitive prostate cancer (mCSPC) according to extent of disease: A study of real-world data
| Autor: | Notario, L., Piulats, J.M., Sala, N., Ferrándiz, U., González, A., Etxániz, O., Villà, S., Buisan, O., Boladeras, A., Heras, L., Del Carpio, L., Roselló, A., Barretina, P., Fina, C., Pardo, J.C., Suárez, J.M., Comet, J., Garcia del Muro, X., Esteve, A., Font, A. |
|---|---|
| Zdroj: | In Annals of Oncology September 2020 31 Supplement 4:S532-S532 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|